Aspira Price to Sales Ratio Trend from 2010 to 2022

AWH
 Stock
  

USD 1.07  0.13  13.83%   

Aspira Womans Price to Sales Ratio is increasing over the last several years with slightly volatile swings. Price to Sales Ratio is estimated to finish at 33.91 this year. During the period from 2010 to 2022 Aspira Womans Health Price to Sales Ratio regressed destribution of quarterly values had coefficient of variationof 118.31 and r-value of  0.44. Aspira Womans Interest Expense is most likely to decrease significantly in the upcoming years. The last year's value of Interest Expense was reported at 48,000. The current Research and Development Expense is estimated to increase to about 5.7 M, while Consolidated Income is projected to decrease to (32.5 M).
  
Check Aspira Womans financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aspira main balance sheet or income statement drivers, such as Direct Expenses of 4 M, Cost of Revenue of 3.2 M or Gross Profit of 3.3 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.0925, PPandE Turnover of 14.04 or Receivables Turnover of 10.21. Aspira financial statements analysis is a perfect complement when working with Aspira Womans Valuation or Volatility modules. It can also supplement various Aspira Womans Technical models . Please continue to the analysis of Aspira Womans Correlation against competitors.

Aspira Womans Quarterly Price to Sales Ratio

28.896

Aspira Price to Sales Ratio Breakdown

Showing smoothed Price to Sales Ratio of Aspira Womans Health with missing and latest data points interpolated. Price to Sales Ratio is figured by comparing Aspira Womans Health stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aspira Womans sales, a figure that is much harder to manipulate than other Aspira Womans Health multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. An alternative calculation method to [PS]; that measures the ratio between a company's [Price] and it's [SPS].Aspira Womans' Price to Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aspira Womans' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 14.62 X10 Years Trend
Increasing
Slightly volatile
   Price to Sales Ratio   
Share
       Timeline  

Aspira Price to Sales Ratio Regression Statistics

Arithmetic Mean 30.61
Geometric Mean 20.98
Coefficient Of Variation 118.31
Mean Deviation 20.15
Median 19.25
Standard Deviation 36.21
Sample Variance 1,312
Range 138.43
R-Value 0.44
Mean Square Error 1,159
R-Squared 0.19
Significance 0.14
Slope 4.05
Total Sum of Squares 15,738

Aspira Price to Sales Ratio History

2012 9.46
2013 19.25
2014 28.48
2015 38.96
2016 18.77
2017 35.21
2018 6.89
2019 15.46
2020 145.31
2021 28.9
2022 33.91

About Aspira Womans Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aspira Womans income statement, its balance sheet, and the statement of cash flows. Aspira Womans investors use historical funamental indicators, such as Aspira Womans's Price to Sales Ratio, to determine how well the company is positioned to perform in the future. Although Aspira Womans investors may use each financial statement separately, they are all related. The changes in Aspira Womans's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aspira Womans's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aspira Womans Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aspira Womans. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Price to Sales Ratio 28.90  33.91 
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aspira Womans without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Pair Trading with Aspira Womans

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womans position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womans will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aspira Womans

0.81AXDXAccelerate Diagnosti Earnings Call  This WeekPairCorr

Moving against Aspira Womans

0.76AGRXAgile Therapeutics Earnings Call  This WeekPairCorr
0.69AIMAim Immunotech Earnings Call  TomorrowPairCorr
0.65AKUAkumin Inc Earnings Call  TodayPairCorr
0.65AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr
The ability to find closely correlated positions to Aspira Womans could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womans when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womans - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womans Health to buy it.
The correlation of Aspira Womans is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womans moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womans Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womans can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Aspira Womans Correlation against competitors. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.